| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 15594.71777 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 23525.70313 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 25668.45313 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 27039.16797 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 31158.69727 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 33671.67578 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 42977.41016 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 45666.51172 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 46868.03516 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 47075.09766 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 47113.91016 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 49351.5625 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 51461.11328 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 52064.92188 | height | CFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 63852.19141 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 67503.39063 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 70469.85156 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 77410.92969 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 83024.63281 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 83685.75781 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 90385.5625 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 91383.76563 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 97604.45313 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 100454.2969 | height | Celecoxib_HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 120099.8672 | height | HFD |
| Reversed phase NEGATIVE ION MODE | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 123069.4141 | height | HFD |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|